NASDAQ
Fusion Pharmaceuticals Inc. (FUSN) has a free cash flow growth of -55.87% as of Friday, May 29, 2026. This represents a 9652.22% decrease compared to its 12-month average of 0.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.